Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (105)	5/23/2000 10:38:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 447

here's the headline from the GNE/DNA release today..... Preliminary Positive Phase II Results for Experimental Anti-VEGF Monoclonal Antibody With Chemotherapy in Lung Cancer Presented At ASCO I've read the release several times now, and have thus far failed to find anything "positive". If they're going to claim that the high dose was effective, they should also "claim" that half that dose kills people. What are they going to do, claim that 15 mg/kg isn't enough? Steammmmmmmmm..............